DVC1-0101 to Treat Peripheral Arterial Disease: A Phase I/IIa Open-label Dose-escalation Clinical Trial

We here report the results of a Phase I/IIa open-label four dose-escalation clinical study assessing the safety, tolerability, and possible therapeutic efficacy of a single intramuscular administration of DVC1-0101, a new gene transfer vector based on a nontransmissible recombinant Sendai virus (rSe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yonemitsu, Yoshikazu, Matsumoto, Takuya, Itoh, Hiroyuki, Okazaki, Jin, Uchiyama, Makiko, Yoshida, Kumi, Onimaru, Mitsuho, Onohara, Toshihiro, Inoguchi, Hiroyuki, Kyuragi, Ryoichi, Shimokawa, Mototsugu, Ban, Hiroshi, Tanaka, Michiko, Inoue, Makoto, Shu, Tsugumine, Hasegawa, Mamoru, Nakanishi, Yoichi, Maehara, Yoshihiko
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3589164/
https://ncbi.nlm.nih.gov/pubmed/23319060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2012.279
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados